Clinical Trials
We have initiated Phase 1 studies for our Treg therapy and our Teff biologic.
7101 Clinical Trial for RA
We have initiated a Phase 1 study to evaluate the safety and proof-of-mechanism of our lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.For more information, please see the 7101 RA study on ClinicalTrials.gov.
Learn More5301 Clinical Trial
We are conducting a Phase 1 study of SBT-11-5301, our effector T cell-modulating biologic, in healthy participants.For more information, please see the 5301 study on ClinicalTrials.gov.
Learn More